Etrasimod data suggests Pfizer's $6.7bn gamble on Arena will...
It's only been two weeks since Pfizer closed its $6.7 billion takeover of Arena Pharmaceuticals, and it already has the positive data it was hoping for with etrasimod, the main asset in the